Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medicare ‘Small Biotech’ Exemption Could Mostly Help Products That Are Neither, PCMA Warns

Executive Summary

The exemption could be sought for small molecule drugs covered by Medicare Part D that have high levels of spending and are marketed by large companies, the Pharmaceutical Care Management Association suggests.

You may also be interested in...



‘Small Biotech Exception’ From Medicare Price Negotiation Granted To Four Drugs For 2026

CMS has not disclosed how many requests for the exception it received but will follow up with applicants regarding its decisions this month.

Medicare Price Negotiation Will Disrupt Rebating In Part D; The Question Is How Much

Congressional Budget Office maps out how current rebating practices may change in Medicare Part D under the drug pricing provisions of the Inflation Reduction Act.

What Exactly Is A ‘Small Biotech’? US Medicare Agency Will Try To Spell It Out

CMS’s new price negotiation authority has an exemption for ‘small biotech’ companies. The agency’s implementation plan suggests that will be a tricky concept to define.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

PS148054

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel